Drug details
Binosto (alendronate sodium effervescent tablets)
type of Bisphosphonate Derivatives, Calcium Metabolism Modifiers
Binosto (alendronate sodium) is a bisphosphonate used in the treatment of osteoporosis in postmenopausal women, and in treatment to increase bone mass in men with osteoporosis.
The drug is often used to treat Osteoporosis .
This drug may have the following side effects:
- headache
- nausea
- diarrhea
- vomiting
- muscle cramps
- dizziness
- constipation
- abdominal or stomach pain
- acid reflux
- indigestion
- musculoskeletal pain
- joint pain or swelling
- gas
- changes in taste
- abdominal bloating
- eye pain, or
- swelling in your hands or feet
The following drugs are related to Binosto, either as a replacement or used together:
- Actonel (risedronate sodium)
- Actonel with Calcium (risedronate sodium with calcium carbonate)
- Fosamax (alendronate sodium)
- Fosamax Plus D (alendronate sodium and cholecalciferol)
- Atelvia (risedronate sodium delayed-release tablets)
- Boniva (ibandronate sodium)
- Boniva Injection (ibandronate sodium injection)
- Miacalcin (calcitonin-salmon)
- Cenestin (synthetic conjugated estrogens)
- Darzalex (daratumumab intravenous injection)
- Didronel (etidronate disodium)
- Menest (estrogens)
- Ogen (estropipate)
- Farydak (panobinostat capsules)
- Ninlaro (ixazomib capsules)